https://www.selleckchem.com/pr....oducts/oligomycin-a.
57), or pulmonary edema ( = .73). The significant finding between groups was a higher rate of reintubation in liver transplant patients with normal PFTs ( = .02). There was no difference in graft survival ( = .53) or patient survival ( = .42). Abnormal PFTs, found in 86% of liver transplant patients, did not correlate with complications, graft failure, or mortality. PFTs contribute to the high cost of liver transplants but do not help predict which patients are at risk of postoperative complications. Abnormal PFTs, found in 86% of